TGFB1 and atrial fibrillation: In future studies, it will be important to determine if ZFP451 expression in the pulmonary myocardium and heart of atrial fibrillation patients is altered in parallel with increased TGFβ expression; if so, this transcription factor might be a viable therapeutic target.